May 10th 2022
Kathryn Ruddy, MD, discusses the use of GnRH agonists in breast cancer.
November 6th 2018
Kathryn Ruddy, MD, associate professor of Oncology, Mayo Clinic, discusses the management of central nervous system (CNS) metastases in HER2-positive breast cancer.
October 13th 2018
Kathryn Ruddy, MD, discusses how genetic testing could impact treatment of patients with breast cancer.